Novel nasal spray effectively prevents influenza infection
The nasal spray reduced influenza virus levels by >99.99 percent, which could safeguard public health if validated in humans.
List view / Grid view
The nasal spray reduced influenza virus levels by >99.99 percent, which could safeguard public health if validated in humans.
The AI model screened the medical records of heart failure patients more accurately, quickly and cheaply, compared to study staff.
Inhibiting mTOR signalling and neutralising mtROS suppressed MCC-PD-1-mediated tumour proliferation in mice.
Six types of inflammation with various cell types and disease pathways identified may provide better treatment of rheumatoid arthritis.
Important step achieved by US researchers as stable and potent immune therapy delivery system eradicates tumours in mouse models of melanoma, colon, and breast cancer, while preventing the formation of future tumour.
A newly developed AAV has shown promise at delivering gene therapies to the brain in mice and non-human primates.
The La Jolla Institute for Immunology and Brigham and Women's Hospital will collaborate to develop a pan-coronavirus vaccine.
Scientists have developed a 3D lung-on-a-chip model of the distal lung and alveolar structures, enabling the study of COVID-19.
SARS-CoV-2 diverts building blocks from glucose production to the assembly of purine bases, researchers have found.
A team have shown that a tumour-suppressing and killing molecule delivered to the brain by stem cells has been successful in mice.
Researchers have used a drug candidate to block a receptor that contributes to the development of autoimmune disease which could be a potential treatment.
Drug Target Review lists its 10 most popular news stories from 2019, summarising the drug targets that you wanted to read about.
Researchers have used single-cell sequencing to map the landscape of myeloid cells in tumours from patients with lung cancer...
New approach restores epithelial function in diarrhoea and inflammatory bowel disease models...
Preclinical study yields previously unreported, potent and generalisable hits representing potential drug targets for hereditary breast, ovarian cancer...